State Opioid Response Grants
ID: 349686Type: Posted
Overview

Buyer

Substance Abuse and Mental Health Services Adminis (HHS-SAMHS-SAMHSA)

Award Range

$0 - $1B

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes
Timeline
    Description

    The Substance Abuse and Mental Health Services Administration (SAMHSA) is offering State Opioid Response Grants aimed at addressing the public health crisis related to opioid misuse and opioid use disorder (OUD) across the United States. Eligible applicants, specifically Single State Agencies (SSAs) and territories, are expected to utilize the funding to enhance access to FDA-approved medications for OUD treatment, support a comprehensive range of prevention and recovery services, and address stimulant misuse, including cocaine and methamphetamine. With an estimated total program funding of $1.48 billion and an expected 59 awards, the application deadline is set for July 1, 2024. For further inquiries, interested parties can contact SAMHSA at OPIOIDSOR@samhsa.hhs.gov or call (240) 276-0300, and additional information can be found at SAMHSA's grant announcement page.

    Point(s) of Contact
    Files
    No associated files provided.
    Similar Opportunities
    Strategic Prevention Framework – Partnerships for Success for States
    Active
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is offering a federal grant opportunity titled "Strategic Prevention Framework – Partnerships for Success for States." This program aims to reduce the onset and progression of substance misuse by supporting the development and delivery of state and community prevention services, thereby enhancing the capacity of local providers to implement evidence-based programs. The grant is particularly significant for states, U.S. Territories, Pacific Jurisdictions, and the District of Columbia, with a total estimated funding of $15.5 million and an award ceiling of $1.25 million for up to 12 awards. Interested applicants should note that applications for FY 2024 are due by February 26, 2024, and for FY 2025 by February 2, 2025. For further inquiries, applicants can contact the Office of Financial Resources at SAMHSA via email at FOACSAP@samhsa.hhs.gov or by phone at 240-276-1940.
    Provider’s Clinical Support System – Medication Assisted Treatment Grant
    Active
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting a grant opportunity titled "Provider’s Clinical Support System – Medication Assisted Treatment Grant" aimed at expanding training for primary care providers in the prevention and treatment of opioid use disorders (OUD) and chronic pain management. This grant seeks to enhance understanding and access to medication-assisted treatment (MAT) through the training of providers authorized to prescribe FDA-approved schedule III medications for addictive disorders, specifically targeting national professional medical organizations such as ASAM, AAAP, AMA, AOAAM, and APA. With an estimated total program funding of $2,000,000 and the expectation of one award, interested applicants can reach out to Humberto Carvalho at Humberto.Carvalho@samhsa.hhs.gov or (240) 276-2974 for further details. The synopsis for this opportunity is expected to be posted on February 15, 2022.
    Strategic Prevention Framework – Partnerships for Success for Communities, Local Governments, Universities, Colleges, and Tribes/Tribal Organizations
    Active
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is offering a federal grant opportunity titled "Strategic Prevention Framework – Partnerships for Success for Communities, Local Governments, Universities, Colleges, and Tribes/Tribal Organizations." This program aims to reduce the onset and progression of substance misuse and related issues by enhancing community-based prevention and mental health promotion services, thereby strengthening local prevention providers' capacity to implement evidence-based programs. With an estimated total program funding of $15,500,000 and an expected 41 awards, the grant has a funding ceiling of $375,000 and is open for applications for FY 2024 and FY 2025, with deadlines on February 26, 2024, and February 21, 2025, respectively. Interested applicants can reach out to the Office of Financial Resources at SAMHSA via email at FOACSAP@samhsa.hhs.gov for further information.
    Rural Communities Opioid Response Program-Overdose Response
    Active
    Health Resources and Services Administration
    The Health Resources and Services Administration (HRSA) is forecasting a grant opportunity titled the Rural Communities Opioid Response Program-Overdose Response, aimed at addressing the overdose crisis in rural areas. This program seeks to enhance access to, capacity for, and sustainability of prevention, treatment, and recovery services for substance use disorder (SUD) in these communities. With an estimated total program funding of $6 million and an award ceiling of $300,000, HRSA anticipates making approximately 20 awards. Interested applicants, particularly small businesses, should note that the estimated synopsis post date is January 16, 2025, with a closing date of April 16, 2025, and can reach out to Sarah O'Donnell at 301-443-0298 or via email at ruralopioidresponse@hrsa.gov for further inquiries.
    Development of Medications to Prevent and Treat Opioid and/or Stimulant Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH), through the National Institute on Drug Abuse (NIDA), has announced a funding opportunity aimed at the development of medications to prevent and treat opioid and stimulant use disorders and overdose. This initiative seeks innovative preclinical and clinical research projects that can lead to FDA-approved therapies, focusing on areas such as prevention of substance use initiation, treatment adherence, and reduction of overdose risks. With a maximum funding amount of $3 million per year over a project period of five years, applicants are encouraged to submit proposals that demonstrate their capability to manage the research effectively, adhering to detailed application instructions. Interested parties can find more information and application details at the NIH grants website, with the application deadline set for September 1, 2025.
    Assisted Outpatient Treatment Program for Individuals with Serious Mental Illness
    Active
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting a grant opportunity titled "Assisted Outpatient Treatment Program for Individuals with Serious Mental Illness." This program aims to implement and evaluate new Assisted Outpatient Treatment (AOT) programs, focusing on evidence-based practices to reduce psychiatric hospitalizations, homelessness, and interactions with the criminal justice system, while enhancing health and social outcomes for individuals with serious mental illness (SMI). The grant is particularly significant as it addresses critical health challenges faced by vulnerable populations, with an estimated total funding of $2 million available for three expected awards. Interested applicants, including states, counties, and mental health systems, can reach out to Katie Hager at katie.hager@samhsa.hhs.gov or (240) 276-1268 for further information, with the synopsis expected to be posted on December 16, 2024.
    Rural Emergency Medical Services Training
    Active
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is offering a federal grant opportunity titled "Rural Emergency Medical Services Training" aimed at enhancing the training of emergency medical service (EMS) personnel in rural areas, particularly focusing on substance use disorders (SUD) and co-occurring disorders (COD). Eligible applicants include rural EMS agencies operated by local or tribal governments, as well as rural non-profit EMS agencies, who will be tasked with developing the capacity of their staff to provide trauma-informed, recovery-based care in emergency situations. This initiative is crucial for addressing the significant need for emergency services in rural communities, with an estimated total program funding of $10.4 million and an award ceiling of $200,000 per grant. Applications for FY 2024 are due by March 20, 2024, and for FY 2025 by March 20, 2025; interested parties can reach out to the Office of Financial Resources at SAMHSA via email at FOACSAT@samhsa.hhs.gov for further information.
    Rural Communities Opioid Response Program-Stimulant Support
    Active
    Health Resources and Services Administration
    The Health Resources and Services Administration (HRSA) is forecasting a grant opportunity titled "Rural Communities Opioid Response Program-Stimulant Support," aimed at enhancing access to prevention, treatment, and recovery services for stimulant use disorder in rural areas. This program seeks to reduce the prevalence and impact of stimulant use disorder, with a focus on coordinated and comprehensive service delivery. The estimated total program funding is $20 million, with an award ceiling of $500,000 and approximately 10 awards expected. Interested applicants, particularly small businesses, can reach out to Sarah O'Donnell at 301-443-0298 or via email at ruralopioidresponse@hrsa.gov for further information. Key deadlines include an estimated synopsis post date of December 16, 2024, and a close date of March 19, 2025, with project start anticipated on September 1, 2025.
    Addiction Technology Transfer Centers Cooperative Agreement
    Active
    Substance Abuse and Mental Health Services Adminis
    The Substance Abuse and Mental Health Services Administration (SAMHSA) is forecasting a grant opportunity titled "Addiction Technology Transfer Centers Cooperative Agreement" aimed at enhancing the behavioral healthcare and primary healthcare workforce for substance use disorder (SUD) treatment and recovery support services. This initiative seeks to accelerate the adoption of evidence-based practices, improve workforce knowledge and skills, and foster collaborations among diverse stakeholders in the field of substance use and co-occurring health disorders. With an estimated total program funding of $8.6 million and an expected 12 awards, eligible applicants include states, territories, Indian tribes, and nonprofit entities. Interested parties can reach out to Humberto Carvalho at Humberto.Carvalho@samhsa.hhs.gov or (240) 276-2974 for further information, with the synopsis expected to be posted on January 30, 2023.
    Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD) (R41/R42 Clinical Trial Optional)
    Active
    National Institutes of Health
    The National Institutes of Health (NIH) has announced a funding opportunity titled "Developing Regulated Therapeutic and Diagnostic Solutions for Patients Affected by Opioid and/or Stimulants use Disorders (OUD/StUD)." This initiative invites Small Business Technology Transfer (STTR) grant applications from small business concerns proposing research projects aimed at developing innovative, FDA-regulated medical products to address the urgent needs of patients suffering from opioid and stimulant use disorders. The program is particularly focused on two scientific areas: pharmacotherapeutics and medical therapeutic and diagnostic devices, including software as a medical device, in response to the national crisis of substance use disorders. Grants of up to $300,000 are available, with a submission deadline of February 14, 2025, and interested applicants can find more information by contacting NIH Grants Information at grantsinfo@nih.gov or visiting the official announcement at https://grants.nih.gov/grants/guide/rfa-files/RFA-DA-24-038.html.